Innovative Hematology, Inc.

What Innovative Hematology, Inc. does

Innovative Hematology, Inc. is a privately held, Indianapolis-based specialty healthcare provider founded in 1998 (operating continuously for more than 25 years) that delivers comprehensive, multi-disciplinary care for patients with blood disorders across Indiana. The organization anchors its clinical operations through the Indiana Hemophilia & Thrombosis Center (IHTC) and a portfolio of condition-specific clinics covering hemophilia, von Willebrand disease, sickle cell disease, thrombosis and clotting disorders, hereditary hemorrhagic telangiectasia (HHT), hemangioma and vascular malformations (HVLM), and other rare bleeding disorders. Care is delivered by an integrated team spanning pediatric and adult hematologists, hospitalists, nurse practitioners, physical therapists, dental hygienists, pharmacists, a psychologist, genetic counselors, social workers, a registered dietitian, and a child life specialist, with outreach clinics extending service across Indiana and a patient portal (powered by athenahealth) supporting access, scheduling, and billing.

The organization monetizes through professional services billing and insurance reimbursement for clinical care, supplemented by a URAC-accredited affiliated specialty pharmacy (Indiana BloodWoRx) that dispenses medications to blood disorder patients, and a clinical research program that conducts trials and trains healthcare providers regionally and nationally. Patient acquisition is sales-led and direct, with patients scheduling via the patient portal and being served across the lifespan from pediatric through adult stages. Educational content and community engagement are distributed through social media (Facebook, LinkedIn, Instagram, X, YouTube) and the newly launched 'We Bleed Too' video podcast.

Name

Innovative Hematology, Inc.

Legal name

Innovative Hematology, Inc.

Website

https://innovativehematology.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Innovative Hematology is an Indianapolis-based specialty practice that provides multi-disciplinary care for blood disorders, including hemophilia, sickle cell disease, and thrombosis, across Indiana through the Indiana Hemophilia & Thrombosis Center and affiliated specialty pharmacy.

Ownership category

akta.pro rank

Product category

Specialty Hematology Care

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKAFAA

Medical Hematology (Benign Hematology)

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAE

Pediatric Hematology & Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAIACAI

Hematology Specialty Pharmaceuticals (Non-malignant)

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

Keywords

• Hematology specialty care
• Blood disorder treatment
• Hemophilia treatment center
• Bleeding disorder clinics
• Sickle cell disease care

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Patient Care Services: Healthcare provider delivering specialized medical care for blood disorders including hemophilia, sickle cell disease, von Willebrand disease, thrombosis, and other rare bleeding disorders. Revenue generated through medical services billing, insurance reimbursements, and clinical care delivery.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Innovative Hematology operates the Indiana Hemophilia & Thrombosis Center (IHTC), delivering specialized diagnostic, treatment, and lifelong disease management services for patients with hemophilia, sickle cell disease, von Willebrand disease, thrombosis, hereditary hemorrhagic telangiectasia (HHT), hemangioma and vascular malformations (HVLM), and other rare bleeding disorders. Care is delivered through a coordinated multi-specialty team across comprehensive clinics, outreach satellite clinics, and dedicated specialty clinics (Joint Health, Sickle Cell Well, HVLM, HHT, GO+), supplemented by the Indiana BloodWoRx specialty pharmacy.

Product overview

Innovative Hematology, Inc. operates a unified healthcare delivery network anchored by the Indiana Hemophilia & Thrombosis Center (IHTC), offering a coordinated portfolio of specialty clinics and patient services. The organization provides comprehensive hematology care through multiple service lines including specialized clinics (Joint Health, Sickle Cell Well, HVLM, HHT, GO+), outreach clinics extending access across Indiana, and a patient portal. Affiliated services include Indiana BloodWoRx (specialty pharmacy) and educational content including the We Bleed Too podcast. This is not a software platform but rather an integrated clinical care network.

Differentiator

Problem solved

Functional benefit

Products and services

• Indiana Hemophilia & Thrombosis Center (IHTC)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Option Care Health: Option Care Health is a national specialty pharmacy and home infusion provider serving patients with complex and chronic conditions. It is comparable to Indiana BloodWoRx as a specialty pharmacy operator serving hematology patients, though with broader therapeutic breadth and national footprint.
• Sanofi (Genzyme/Sanofi Rare Disease): Sanofi, through its rare disease franchise including Genzyme, develops and markets therapies for hemophilia and rare blood disorders. It is comparable as a pharmaceutical incumbent serving the same patient population, providing factor replacement therapies and emerging treatments for conditions Innovative Hematology treats.
• Accredo (Express Scripts): Accredo is a large specialty pharmacy division of Express Scripts serving patients with complex conditions including hemophilia and other blood disorders. It is comparable as a specialty pharmacy serving the same disease state, though at much larger national scale and as part of a broader pharmacy benefit manager.
• CSL Behring: CSL Behring is a global biotherapeutics company and a leading manufacturer of coagulation and bleeding disorder therapies. It is comparable as a major stakeholder in the hematology ecosystem, serving the same patient population Innovative Hematology treats, though as a therapy manufacturer rather than a care provider.
• Takeda Pharmaceutical (Shire/Baxalta): Takeda, through its acquisition of Shire/Baxalta, is a leading manufacturer of hemophilia therapies. It is comparable as a key therapy provider to the patient population Innovative Hematology serves, operating in the same hematology disease states though as a global pharmaceutical manufacturer.

Regional players

• Riley Hospital for Children at IU Health: Riley Children's is a pediatric academic medical center in Indianapolis providing pediatric hematology care including sickle cell and hemophilia programs. It is comparable as a regional provider of pediatric hematology services in the same Indiana market, though as part of a large academic health system.

Direct peers

• Versiti: Versiti is a blood services and hematology organization operating blood centers and providing specialized hematology diagnostic and clinical services. It is directly comparable to Innovative Hematology in providing specialized blood disorder care, though with a broader geographic footprint across multiple states.
• Soleo Health: Soleo Health is a specialty pharmacy and infusion services company with focused expertise in hemophilia, immune deficiencies, and other complex conditions. It is directly comparable to Innovative Hematology's specialty pharmacy operation in serving bleeding disorder patients with specialty medications.
• BioRx: BioRx is a specialty pharmacy focused exclusively on hemophilia and bleeding disorders, providing factor products and clinical support to patients nationwide. It is directly comparable to Innovative Hematology's Indiana BloodWoRx specialty pharmacy operation in serving the same patient population with similar therapies.
• Nufactor: Nufactor is a specialty pharmacy focused on hemophilia and immune disorders, providing factor products and clinical care services to patients nationwide. It is directly comparable to Indiana BloodWoRx as a specialty pharmacy dedicated to the same bleeding disorder patient population.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/innovativehem
• YouTubeyoutube.com/@InnovativeHematology/playlists
• Facebookfacebook.com/InnovativeHematology
• LinkedInlinkedin.com/company/innovative-hematology-inc
• Instagraminstagram.com/innovativehematology

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Hematology, Inc.